Marcin Ufnal, MD, PhD, is a Professor at the Medical University of Warsaw. His work spans experimental, clinical, and translational cardiovascular and metabolic disease science, with expertise in pulmonary hypertension, right ventricular failure, heart failure, chronic kidney disease, obesity, and gut microbiota–derived mechanisms relevant to cardiometabolic risk.
He has been a senior author on close to 100 peer-reviewed publications and has received multiple international awards.
In parallel, he has built a drug-development track record in both big pharma and biotech, including leadership roles such as Executive Clinical Research Director and Global Clinical Head. In these positions, he has been responsible for clinical programmes across pulmonary hypertension, heart failure, chronic kidney disease, and anticoagulation.
